The International Lyme and Associated Diseases Society (ILADS) recently published Evidence-based guidelines for the management of Lyme disease as a supplement to the January/February 2004 issue of Expert Review of Anti-infective Therapy.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.